Osaka, Japan

Ken Ishii

This inventor holds 17 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Malaria Immunology. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Osaka University, Nippon Zenyaku Kogyo Co., Ltd.. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken Ishii. Retrieved from https://idiyas.com/inventor/ken-ishii-6j7w26c2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 47.1

 

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 168(Granted Patents)


Location History:

  • Columbia, MD (US) (2009 - 2012)
  • Rockville, MD (US) (2011 - 2013)
  • Suita, JP (2014)
  • Osaka, JP (2005 - 2019)

Company Filing History:


Years Active: 2005-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Malaria Vaccine
Oligodeoxynucleotide
Adjuvant
Immune Response
Hemozoin Induction
Beta-Hematin Crystal
Cationic Liposomes
Natural Immunity
Therapeutic Medicine
Preventative Medicine
CpG Oligonucleotides
Immunoadjuvant Composition
17 patents (USPTO):Explore Patents

Title: Ken Ishii: Innovator in Malaria Research

Introduction

Ken Ishii is a prominent inventor based in Osaka, Japan, known for his significant contributions to malaria research. With a total of 17 patents, he has developed innovative methods for detecting and measuring malaria infections, as well as for screening potential vaccines and therapeutic agents.

Latest Patents

Ishii's latest patents include groundbreaking work on the detection and measurement of malaria infection utilizing natural immunity through hemozoin induction. His inventions provide methods for diagnosing malaria by detecting HZ-induced, TLR9-mediated, and MyD88-dependent innate immune activity. Additionally, he has developed a method for producing beta-hematin crystals, which are essential for vaccine adjuvant compositions. These crystals exhibit unique needle-like morphology and specific diffraction patterns, making them valuable in the fight against malaria.

Career Highlights

Throughout his career, Ken Ishii has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Osaka University. His work has significantly advanced the understanding and treatment of malaria, showcasing his dedication to public health and scientific innovation.

Collaborations

Ishii has collaborated with notable colleagues, including Dennis M Klinman and Daniela Verthelyi, further enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Ken Ishii's innovative work in malaria research exemplifies the importance of scientific inquiry and collaboration in addressing global health challenges. His contributions continue to pave the way for advancements in the detection and treatment of malaria infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…